Publications by authors named "Miriam Bach"

Claim this Profile
C
Causes of death in patients with atrial fibrillation anticoagulated with rivaroxaban: a pooled analysis of XANTUS.
Paulus Kirchhof, Sylvia Haas, Pierre Amarenco, Alexander G G Turpie, Miriam Bach

Europace· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cancer-Associated ThrOmboSIs - Patient-Reported OutcoMes With RivarOxaban (COSIMO) - Baseline characteristics and clinical outcomes.
Anthony Maraveyas, Jan Beyer-Westendorf, Agnes Y Lee, Lorenzo G Mantovani, Yoriko De Sanctis, Miriam Bach

Res Pract Thromb Haemost· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Patient-reported outcomes associated with changing to rivaroxaban for the treatment of cancer-associated venous thromboembolism - The COSIMO study.
Alexander T Cohen, Anthony Maraveyas, Jan Beyer-Westendorf, Agnes Y Y Lee, Kerstin Folkerts, Miriam Bach

Thromb Res· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Investigation of Electromechanical Properties on 3-D Printed Piezoelectric Composite Scaffold Structures.
Tutu Sebastian, Miriam Bach, Andreas Geiger, Tony Lusiola, Lucjan Kozielski

Materials (Basel)· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Anticoagulation Treatment in Cancer-Associated Venous Thromboembolism: Assessment of Patient Preferences Using a Discrete Choice Experiment (COSIMO Study).
Nils Picker, Agnes Y Lee, Alexander T Cohen, Anthony Maraveyas, Jan Beyer-Westendorf, Miriam Bach

Thromb Haemost· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of gender: Rivaroxaban for patients with atrial fibrillation in the XANTUS real-world prospective study.
A John Camm, Pierre Amarenco, Sylvia Haas, Miriam Bach, Paulus Kirchhof

Clin Cardiol· December 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Outcomes associated with non-recommended dosing of rivaroxaban: results from the XANTUS study.
Pierre Amarenco, Sylvia Haas, Susanne Hess, Paulus Kirchhof, Marc Lambelet, Miriam Bach

Eur Heart J Cardiovasc Pharmacother· April 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-world vs. randomized trial outcomes in similar populations of rivaroxaban-treated patients with non-valvular atrial fibrillation in ROCKET AF and XANTUS.
A John Camm, Pierre Amarenco, Sylvia Haas, Susanne Hess, Paulus Kirchhof, Miriam Bach

Europace· March 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reply: Anticoagulants for Cardioembolism Prevention in Atrial Fibrillation Patients: Potential Bias From Real-World Studies.
Paulus Kirchhof, Miriam Bach, A John Camm

J Am Coll Cardiol· November 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
COSIMO - patients with active cancer changing to rivaroxaban for the treatment and prevention of recurrent venous thromboembolism: a non-interventional study.
Alexander T Cohen, Anthony Maraveyas, Jan Beyer-Westendorf, Agnes Y Y Lee, Lorenzo G Mantovani, Miriam Bach

Thromb J· September 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Global Prospective Safety Analysis of Rivaroxaban.
Paulus Kirchhof, Ghazi Radaideh, Young-Hoon Kim, Fernando Lanas, Sylvia Haas, Miriam Bach

J Am Coll Cardiol· July 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of Osteopathic Cranial Manipulative Medicine on Visual Function.
Austin Bach, Miriam Bach, Stephanie Frankel

J Am Osteopath Assoc· November 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Spotlight on advances in VTE management: CALLISTO and EINSTEIN CHOICE.
Miriam Bach, Rupert Bauersachs

Thromb Haemost· September 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The perfect electronic medical record system.
Austin Bach, Moishe B Singer, Miriam Bach

J Am Osteopath Assoc· October 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Human cytomegalovirus inactivates the G0/G1-APC/C ubiquitin ligase by Cdh1 dissociation.
Lüder Wiebusch, Miriam Bach, Ralf Uecker, Christian Hagemeier

Cell Cycle· October 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Novel RGD lipopeptides for the targeting of liposomes to integrin-expressing endothelial and melanoma cells.
Peter Hölig, Miriam Bach, Tina Völkel, Thomas Nahde, Sven Hoffmann

Protein Eng Des Sel· May 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Isolation from phage display libraries of lysine-deficient human epidermal growth factor variants for directional conjugation as targeting ligands.
Miriam Bach, Peter Hölig, Eva Schlosser, Tina Völkel, Andreas Graser

Protein Eng· December 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis